Research Article | Open Access
M. P. Montet, E. Jamet, S. Ganet, M. Dizin, S. Miszczycha, L. Dunière, D. Thevenot, C. Vernozy-Rozand, "Growth and Survival of Acid-Resistant and Non-Acid-Resistant Shiga-Toxin-Producing Escherichia coli Strains during the Manufacture and Ripening of Camembert Cheese", International Journal of Microbiology, vol. 2009, Article ID 653481, 10 pages, 2009. https://doi.org/10.1155/2009/653481
Growth and Survival of Acid-Resistant and Non-Acid-Resistant Shiga-Toxin-Producing Escherichia coli Strains during the Manufacture and Ripening of Camembert Cheese
Growth and survival of acid-resistant (AR) and non-acid-resistant (NAR) Shiga-toxin-producing Escherichia coli (STEC) strains were investigated during the manufacture and ripening of microfiltered milk Camembert cheeses. The induction of acid resistance of the STEC strains in cheeses was also studied. Six different mixtures of AR and/or NAR STEC strains were inoculated separately into microfiltered milk at a level of CFU . The STEC counts (AR and NAR) initially increased by 1 to 2 CFU during cheese-making. Thereafter, the populations stabilized during salting/drying and then decreased during the early stages of ripening. Exposing the STEC strains in artificially inoculated cheeses to simulated gastric fluid (SGF - pH: 2.0) reduced the number of NAR strains to undetectable levels within 40 minutes, versus 120 minutes for the AR STEC strains. AR and NAR STEC were able to survive during the manufacture and ripening of Camembert cheese prepared from microfiltered milk with no evidence of induced acid tolerance in NAR STEC strains.
Shiga-toxin- (Stx-) producing Escherichia coli strains, including E. coli O157:H7, are a worldwide cause of human disease with a wide spectrum of symptoms ranging from mild diarrhea to life-threatening hemolytic-uremic syndrome (HUS). The Stx-producing family of human disease-associated E. coli is also characterized by its diversity of toxin type (i.e., lysogenic either for the Stx1-encoding phage or the Stx2-encoding phage, or with both lysogens) and by its O:H serotype range [1, 2].
In spite of diverse virulence characteristics, one common trait that emerges very clearly is that most of these strains have the ability to withstand gastric acidity [3–6] or the conditions in acidic foods [7–9]. It is noteworthy that acid tolerance plays a vital role in the survival and virulence of diarrheagenic E. coli strains [10–12]. The ability of E. coli O157:H7 strains to survive in acidic conditions has been studied extensively [13–16], but there are few reports about the tolerance of non-O157 STEC serogroups to organic acids in foods [17, 18]. It is thought that acid resistance and/or induction of acid tolerance may enable pathogens to survive gastrointestinal acidity better and so, ultimately, cause disease [19–22]. Cattle are considered to be a major reservoir of E. coli O157:H7 for human infection . The pathogen has been isolated from raw milk , and multiple outbreaks of E. coli O157:H7 linked to the ingestion of raw milk and dairy products have been reported [25, 26]. Several authors have studied the ability of E. coli O157:H7 to grow and survive in different types of cheese. In fresh cheese, E. coli O157:H7 increased by 2 log (CFU per gram) during cheese manufacture , but total inactivation was obtained during heat treatment ( for more than 1.5 hours) of the curd and whey. Reitsma and Henning (1996) found that this microorganism was able to grow during Cheddar cheese manufacture, even with an initial inoculum in milk of only . E. coli O157:H7 also survived the manufacture and storage of Camembert and Feta cheeses at for 65 and 75 days, respectively .
Moreover, this pathogen was able to survive all stages of smear-ripened cheese production for up to 70 days postmanufacture .
E. coli O157:H7 was not eliminated from goat's milk lactic cheese, made with raw milk, because this organism tolerates the low pH  and low temperatures [31, 32] which characterize the manufacturing and ripening process.
Surprisingly, studies on contamination of milk, or its products, with non-O157 E. coli have been limited. Two studies from France have reported STEC prevalence in cheeses [33, 34], 3 studies reported results for ewes' and caprine milk cheeses [35–37] and, very recently, a study described the prevalence of STEC in Swiss raw milk cheeses . Moreover, there are no published experiments evaluating the growth or survival of non-O157 STEC in cheeses.
However, non-O157 E. coli infections are, within European member states, considered to be at least as important as E. coli O157:H7 infections though they are thought to be generally underdiagnosed . For example, in Italy , Denmark , and Germany , more than 40% of the confirmed cases of STEC-related HUS were caused by non-O157 STEC. More recently, in 2005, French raw milk Camembert-type cheeses contaminated by Escherichia coli O26 and O80 caused 16 HUS cases and a national and international recall of the entire production of cheeses . Other human infections with non-O157 STEC from dairy products are well documented [44–47]. These outbreaks suggest that the acid tolerance of the non-O157 STEC strains, like the O157 STEC strains, enables these bacteria to survive in moderately acidic food. Acid tolerance is defined by the growth of log-phase cultures at a moderately low pH (pH 5.5 to 6.0) inducing mechanisms of survival in the more extreme acid conditions of pH 2.5 . A similar phenomenon, termed the “acid tolerance response,” has been demonstrated in S. typhimurium [49, 50].
The purpose of the present work was to address the question of whether the acidic resistance confers an ecological superiority. This potential ecological superiority of STEC strains was evaluated by the ability of acid-resistant (AR) and non-acid-resistant (NAR) STEC strains to survive the fermentation process of Camembert-type cheeses.
In a previous study, we have investigated the fate of E. coli O157:H7 during the manufacture and ripening of raw goat's milk lactic cheeses and noted that E. coli O157:H7 was able to survive the cheese-making process .
The main objectives of the present study were firstly to evaluate the growth and survival of AR and NAR Shiga-toxin-producing E. coli strains and, secondly, to check whether microfiltered milk Camembert cheeses could induce acid tolerance in inoculated NAR STEC strains.
2. Materials and Methods
2.1. Bacterial Strains and Culture Conditions
A collection of 62 STEC strains were isolated during previous French epidemiological studies, whose purpose was to determine STEC contamination prevalence in dairy products, in pork, and in the environment [34, 52–54].
With the aim of evaluating the ability of these bacteria to survive exposure to acid, we used the protocol described by Castanie-Cornet et al. , in which three AR mechanisms were tested. These mechanisms are as follows:(i) AR1: oxidative system (glucose–repressed system),(ii)AR2: system depending on the presence of glutamate,(iii)AR3: system depending on the presence of arginine. A fourth mechanism is a fermentative acid resistance system. It was tested according to the method previously described by Large et al. .
Four AR STEC and four NAR STEC strains were selected from a previous study (data not shown). The survival rate of the strains in the presence of glucose and amino acids is displayed in Table 1. Two spontaneous nalidixic acid-resistant mutants were selected in vitro for each AR and NAR STEC strain, previously selected by plating STEC on BHI agar containing nalidixic acid (0.1 to 10 g/mL) in increasing concentrations, using the protocol described by Truong et al. . Three rifampicin and three spectinomycin mutants were selected using the same protocol. The antibiotic susceptibility of these AR or NAR mutants is shown in Table 1. To follow the growth of these strains during the manufacture and ripening of the Camembert cheese, spontaneous antibiotic-resistant derivatives (nalidixic acid, rifampicin, and spectinomycin) were isolated. We carefully checked that the chosen resistant derivatives were neither affected in their growth rate nor in their acid-resistance properties (data not shown).
|aOnt: O type not corresponding to any serogroup
between O1 and O 174.bP production.cP,
positive.N, negative.AR1: oxidative system
system), AR2: system depending on the presence of glutamate, AR3: system
depending on the presence of arginine, AR4: system depending on the presence of
Rifampicin resistance, Spec: Spectinomicin resistance, Nal: Nalidixic acid resistance.|
2.2. Microfiltered Cow Milk
Raw cow milk samples were collected aseptically from the bulk storage tank after it had been cooled to <5°C and maintained refrigerated at for transportation to Actilait. Cheeses were made with raw cow milk standardized  by microfiltration. Raw milk was microfiltered at through a ceramic Membralox membrane (Pall Exekia, Bazet, France).
The microfiltered cow milk was analyzed, in order to check that it was not contaminated by STEC, by performing a Polymerase Chain Reaction (PCR) for Shiga-toxin coding genes (stx genes) after an enrichment step, as described by Fremaux et al. .
2.3. Inoculation Procedure and Preparation of the STEC Mixtures
Cultures of antibiotic-resistant STEC strains were maintained at in cryopreservative beads (STARLAB, Bagneux, France). Prior to preparing the inoculation mixtures, each culture of antibiotic-resistant STEC strains was incubated overnight (18 hours) in LB broth at . Strains were grown individually at for 24 hours in LB broth, with or without antibiotics, to reaffirm that the strains retained resistance. All overnight cultures were centrifuged at for 10 minutes. Cells were washed twice in 0.1% peptone water and suspended in 0.1% peptone water to achieve the required inoculation level by standardization of the absorbance at using a spectrophotometer (BioPhotometer, Eppendorf, Le Pecq, France). Mixtures were prepared by combining the 3 adequate STEC strains in equal amounts. They were designed corresponding with the need to have 3 different antibiotic-resistant or non-resistant phenotypes in the same mixture. The 6 mixtures of STEC strains used for this experimentation are detailed in Table 2.
The STEC population in each mixture was confirmed by plating of the suspension onto LB-A plates supplemented with the appropriate antibiotic to verify the initial inoculum levels. Six millilitres of mixture were inoculated into 6.5 L of milk to obtain a final concentration in the microfiltered milk of approximately of STEC.
Twelve batches of cheeses were prepared (two batches per mixture) and 4 batches of uninoculated cheese samples served as negative controls (1 batch per manufacturing day).
2.4. Cheese Manufacture
Artisanal microfiltered cow's milk lactic cheeses were prepared following the industrial specifications of the French Institute of cheese (Actilait).
The milk was inoculated ( per 100 kg) with mesophilic starters MM100 (Lactococcus lactis subsp. lactis, cremoris, and lactis biovar diacetylactis), (Rhodia, Dangé-Saint-Romain, France) as well as ripening flora Penicillium camemberti (Pc P9, 4 doses per 1000 kg Cargill, St Germain en Laye, France), Geotrichum candidum (GCA, 2 doses per 1000 kg, Cargill) and 10.5 mL of a solution of was also added per 100 kg of milk. The inoculated milk was matured for 2 hours at and renneting was carried out using 30 mL of rennet per 100 L of milk (at of chymosin, Berthelot, ABIA S.A. Meursault, France). The milk coagulated after 8 minutes and was left undisturbed until the pH decreased to 6.15. The curd was cut into 3 cm cubes, healed for 30 minutes (pH minimum = 6.00), drained and transferred to cylindrical plastic moulds. Cheeses drained for 20–22 hours at were turned twice during this time. Cheeses weighing approximately 250 g were removed from the mould, and the temperature of the cheese-making chamber was reduced to . After 20 hours, the cheeses were plunged into a saturated brine solution at for 25 minutes. Cheeses were dried at for 5 hours and matured at and 95% relative humidity for 20 days, then finally packaged and stored at .
The manufacturing protocol for lactic cheeses made with microfiltered is outlined in Figure 1.
2.5. Sampling Steps
Physicochemical and bacteriological analyses were performed at the following steps.Step 1: Microfiltered milk before the maturation stage.Step 2: Curd during draining (3 hours 20 minutes).Step 3:Cheese at the end of the moulding stage (3 hours 45 minutes).Step 4:Cheese after salting (1 day).Step 5:Cheese after drying (1 day).Step 6:Cheese at the middle of the ripening stage (10 days).Step 7:Cheese at the end of ripening (20 days).
2.6. Microbiological Analysis
During cheese manufacture, 25 mL samples of microfiltered milk or 25 g of drained curd or cheese (rind and core) were sampled and homogenized with 225 mL of Buffered Peptone Water (BPW, bioMérieux, Marcy l'Etoile, France) in a sterile bag filter (BagSystem 400 mL Model+, Interscience, Saint Nom la Breteche, France) and stomached for 30 seconds (Stomacher Mix1, AES Laboratory, Bruz, France). The filtered liquid was diluted in BPW and spread, using spiral plating (WASP Spiral plating, AES Laboratory, Bruz, France), onto LB-A plates. LB-A plates were supplemented with rifampicin , spectinomycin (), or nalidixic acid (), when appropriate, and incubated for 24 hours at . Enumeration of the colonies was performed with an automatic colony counter EC2 easy count 2 (AES Laboratory, Bruz, France).
2.7. Physical-Chemical Measurements
The pH was measured for each cheese (inoculated or not inoculated) at each time of sampling. For the chemical measurements, analyses were performed on the raw milk after microfiltration and on the noninoculated (negative controls) cheeses after 1 day (before brining) and 20 days (end of the ripening stage). Milk fat content was determined by the acido-butyrometric method of Gerber, according to AFNOR (NF V 04-210), and the milk protein rate was obtained using the amido black method (AFNOR, NF V 04-216). Cheese moisture content was determined with an infrared-dryer (Précisa XM60), according to AFNOR (NF V 04-282), and the cheese fat content was measured by the Heiss butyrometric method . The ripened cheese salt content was determined using a chloride analyzer (AFNOR, NF V 04-288).
Cheese pHs were measured using a penetration electrode (pH meter 330, Fisher Bioblock Scientific, F67403 Illkirch Cedex, France).
2.8. Exposure of STEC, Present in Artificially Inoculated Cheeses, to Simulated Gastric Fluid (SGF)
Simulated gastric fluid was prepared accorded to the protocol used by Yuk and Marshall . More precisely, simulated gastric fluid consisted of of proteose-peptone (Fluka-Biochemika, Switzerland), of D-glucose (Fluka-Biochemika, Switzerland), of NaCl (Sigma-Aldrich, Lyon, France), of KH2PO4 (Merck Sharp & Dohme, Paris, France), of (Sigma-Aldrich, Lyon, France), of KCl (Sigma-Aldrich, Lyon, France), of ox bile (Sigma-Aldrich, Lyon, France), of lysozyme (Sigma-Aldrich, Lyon, France), and of pepsin (Sigma-Aldrich, Lyon, France). The final pH was adjusted to 1.5 using sterile 5.0 N HCl (Merck Sharp & Dohme, Paris, France). All compounds were autoclaved separately, except for the ox bile, lysozyme, and pepsin which were filter sterilized, followed by aseptic mixing.
However, 90 mL of SGF (pH 1.5), at , were added aseptically to 10 g of inoculated cheese sampled at the end of the ripening stage. To obtain a final inoculated SGF at pH 2.5, the pH of each sample was lowered to 2.5 using (5.0 N) HCl.
For the enumeration of each STEC strain (Table 1) belonging to the different mixtures used for the inoculation of the milk, homogenate cheese samples were taken at regular time intervals. Viable cell densities were determined by spiral plating appropriate dilutions in TS onto LB-A plates containing rifampicin , spectinomycin , or nalidixic acid . LB-A plates were incubated at for 24 hours and enumeration of the colonies was performed with an automatic colony counter EC2 easy count 2 (AES Laboratory, Bruz, France).
3.1. PH and Physicochemical Properties during Manufacture and Ripening of The Cheeses
Cheese production was performed in a dairy laboratory in order to provide commercial conditions during production. The chemical composition of the cheese samples produced from the microfiltered milks is shown in Table 3. The fat and protein content in the microfiltered milks were 37.00% and 32.58% w/w, respectively.
|Average values in 4 uninoculated cheeses as negative
controls.Mean standard deviation.|
The pH of the milk was . It declined slightly to 6.03 (SD: ±0.02) during the first 4 hours (draining of curdled milk). Then the pH decreased markedly from 6.03 to 4.65 (SD: ±0.05) at the end of moulding step (24 hours). The pH remained almost stable until the 10th day (4.64 to 4.75) (SD: ±0.02) and increased slightly over the last 10 days of the ripening period to a pH of 5.11 (SD: ±0.03) (Table 4).
|pH values for
each cheese, inoculated or not, and at each time of sampling (i.e., 10 pH
measures per time of sampling).Mean ± standard deviation.|
3.2. Survival of STEC during Lactic Cheese Manufacture
STEC was never isolated from any of the milk samples collected from the bulk storage tank nor from any of the negative control cheeses.
There were no differences between the counts of NAR and AR STEC strains during the manufacture and ripening of the microfiltered milk lactic cheeses.
As an example, Figure 2 shows the survival of 4 STEC mixtures: the AR2 (3 AR STEC strains), AS2 (3 NAR STEC strains), ARSSb2 (2 NAR and 1 AR STEC strains), and ASRRa2 (2 AR and 1 NAR STEC strains) mixtures during cheese manufacture (Table 2).
In general, whatever the mixture used, STEC counts increased by a range of 1 to 2 during the first steps of the cheese manufacturing and remained relatively stable after salting until the drying stage of the cheeses. Then, during ripening (20 days), the counts of only one NAR STEC strain decreased to . The other AR or NAR STEC strains were all counted at levels ranging from to (Figure 2).
3.3. Survival of STEC in Simulated Gastric Fluid, PH 2
At the end of ripening (20 days), samples of inoculated cheeses were placed in simulated gastric fluid where the numbers of surviving STEC cells were assessed at 5, 10, 20, 30, 40, 50, 60, 90, and 120 minutes.
Exposure to SGF (pH: 2.5) reduced the number of NAR STEC strains to undetectable levels within 40, 50, and 60 minutes for ANR , ANR , and , respectively. In contrast to the NAR STEC strains, all the AR STEC strains survived an exposure of more than 120 minutes in SGF at pH 2.5 (Table 5).
|aPercentage of survival calculated as the
number of CFU per gram remaining
after the acid treatment divided by the initial CFU per gram at time zero.|
Multiple applications of low levels of acid stress during the life cycles of Escherichia coli O157:H7 and other pathogens might increase their likelihood for survival in foods and may enhance the development and establishment of stress-adapted strains with potentially increased virulence in food environments [61–63]. Although acid tolerance in E. coli O157:H7 is normally transient, being induced at low pH [14, 30, 64, 65], some outbreak strains (e.g., ATCC 43895) have attained a permanently high, pH-independent acid resistance , probably because of an evolutionary response to severe acid stress.
The objective of the present study was to investigate the growth and survival of AR and NAR STEC strains in Camembert-type cheeses. None of our findings have been subjected to a statistical analysis since we have used mixtures of 3 STEC strains for the inoculation of the milk and, hence, some interaction between STEC strains could occur. The use of mixtures, instead of a single strain, is explained by the limited number of batches (16) allowed by Actilait and the decision to study the kinetics of 8 different STEC strains. Moreover, it was not possible to study pathogenic STEC strains, such as E. coli O157:H7 or E. coli O26, due to the lack of safety level/P3 laboratories.
The number of STEC increased from 1 to at the beginning of the cheese manufacture, whilst the pH decreased slightly from 6.45 (milk pH) to 6.03 (first 4 hours). Much of this initial increase could be attributed to the entrapment of STEC in the curd during coagulation followed by further concentration during whey drainage. Then we noted a plateau phase in the growth of STEC from the “cheese at the end of moulding” stage (pH: 4.65) to the “cheese after drying” stage (pH: 4.66). From the middle of ripening (10 days, pH: 4.75) to the end of ripening (20 days, pH 5.11), the STEC population decreased markedly. In much the same way, after 24 hours of manufacture and storage of Camembert cheese inoculated at , Ramsaran et al.  observed an increase in E. coli O157:H7 counts of about . This increase was followed by a decrease in the counts of E. coli O157:H7 in all of the cheeses throughout ripening and storage at .
Vernozy-Rozand et al.  showed that significant numbers of viable E. coli O157:H7 could be detected in raw goat milk lactic cheeses even 42 days after processing. In Cheddar cheeses, aged for 60 and 120 days, and stored at , the E. coli O157:H7 population was reduced by less than 2 log . Marek et al.  reported that E. coli O157:H7 could persist in unpasteurized Cheddar cheese whey inoculated at or for up to 2-3 weeks of storage at 4, 10, or . The results of Maher et al.  showed the presence of E. coli O157:H7 even after 90 days in the rind and after 50 days in the core of smear ripened cheese produced from raw milk.
The acid adaptation response is a phenomenon by which microorganisms show an increased resistance to environmental stress after exposure to a moderate acid environment. In this study, the acid adaptation of 4 NAR STEC strains was not induced by the slow and mild acid conditions (4.65–4.75) found during the lactic cheese process because these strains were rapidly destroyed during the strong acid exposure in simulated gastric fluid (pH 2.5).
Hsin-Yi and Chou  noted the same effects in fermented milk but a completely opposite effect in acid fruit juice. The authors explained that acid adaptation might lead to an increased susceptibility of the test organism to antimicrobials, such as bacteriocins, hydrogen peroxide, ethanol, and diacetyl, produced by lactic acid bacteria in milk products. The effect of increasing susceptibility to these antimicrobials, due to acid adaptation, may outweigh the effect of enhancing acid tolerance, reducing the survival of acid-adapted E. coli O157:H7 in the milk products. Jordan et al.  observed that E. coli O157:H7 is able to induce an adaptive tolerance response (ATR) when exposed to mild acid conditions, thus conferring a higher resistance on subsequent exposure to strong acid conditions. Bergholz and Whittam  studied the survival of enterohaemorrhagic Escherichia coli of serotypes O157:H7, O26:H11, and O111:H8 in a simulated gastric environment. Their results indicated that E. coli O157:H7 strains were better able to survive in a simulated gastric environment than the STEC strains belonging to the two other serogroups. The authors indicated that this difference was reduced when cultures were held at stationary phase for longer periods of time, suggesting that E. coli O157:H7 cells rapidly achieve an enhanced state of AR in the early stationary phase, an ability that may underlie the low infectious dose of this pathogen.
The present study indicates that AR and NAR STEC strains, when initially present at in milk, would most likely survive artisanal Camembert-type cheese manufacture and ripening (20 days). The biggest decrease was observed for an NAR STEC strain () whose counts reached at 20 days. Even if we must keep in mind that the inoculation levels were certainly higher than those observed in naturally contaminated milk, the low infectious dose associated with pathogenic STEC suggests that the 20 day ripening period of these cheeses may not guarantee a safe product for consumers if STEC are present in the raw milk. Consequently, good milk hygiene is crucial in order to reduce the risk of the presence of pathogens in the raw milk cheeses. Moreover, acid adaptation of NAR STEC strains during the manufacture of cheeses prior to their exposure to simulated gastric fluid did not increase the acid resistance of the bacteria. On the basis of these results, additional investigations will be undertaken to evaluate the behavior of STEC during the manufacture of cheeses using a rapid curdling phase linked to a greater drop in acidity than that employed in the present cheese technology.
This research was supported by funds from the National Agency of Research (ANR), (ANR-05-PNRA-021).
- J. B. Kaper, J. P. Nataro, and H. L. T. Mobley, “Pathogenic Escherichia coli,” Nature Reviews Microbiology, vol. 2, no. 2, pp. 123–140, 2004.
- J. Meng and M. P. Doyle, “Escherichia coli O157: H7 and other Shiga toxin-producing E. coli strains,” in Microbiology of Shiga Toxin-Producing Escherichia coli in Foods, J. B. Kaper and A. D. O'Brien, Eds., pp. 92–108, AMS Press, Washington, DC, USA, 1998.
- J. W. Foster and M. Moreno, “Inducible acid tolerance mechanisms in enteric bacteria,” in Bacterial Responses to pH, Novartis Foundation Symposia no. 221, pp. 55–69, John Wiley & Sons, New York, NY, USA, 1999.
- J. Lin, I. S. Lee, J. Frey, J. L. Slonczewski, and J. W. Foster, “Comparative analysis of extreme acid survival in Salmonella typhimurium, Shigella flexneri, and Escherichia coli,” Journal of Bacteriology, vol. 177, no. 14, pp. 4097–4104, 1995.
- D. S. Merrell and A. Camilli, “Acid tolerance of gastrointestinal pathogens,” Current Opinion in Microbiology, vol. 5, no. 1, pp. 51–55, 2002.
- S. R. Waterman and P. L. C. Small, “Acid-sensitive enteric pathogens are protected from killing under extremely acidic conditions of pH 2.5 when they are inoculated onto certain solid food sources,” Applied and Environmental Microbiology, vol. 64, no. 10, pp. 3882–3886, 1998.
- D. Morgan, C. P. Newman, D. N. Hutchinson, A. M. Walker, B. Rowe, and F. Majid, “Verotoxin producing Escherichia coli O157 infections associated with the consumption of yoghurt,” Epidemiology and Infection, vol. 111, no. 2, pp. 181–187, 1993.
- H. E. Uljas and S. C. Ingham, “Combinations of intervention treatments resulting in 5--unit reductions in numbers of Escherichia coli O157:H7 and Salmonella typhimurium DT104 organisms in apple cider,” Applied and Environmental Microbiology, vol. 65, no. 5, pp. 1924–1929, 1999.
- T. Zhao, M. P. Doyle, and R. E. Besser, “Fate of enterohemorrhagic Escherichia coli O157:H7 in apple cider with and without preservatives,” Applied and Environmental Microbiology, vol. 59, no. 8, pp. 2526–2530, 1993.
- M.-P. Castanie-Cornet, T. A. Penfound, D. Smith, J. F. Elliott, and J. W. Foster, “Control of acid resistance in Escherichia coli,” Journal of Bacteriology, vol. 181, no. 11, pp. 3525–3535, 1999.
- S. B. Price, J. C. Wright, F. J. DeGraves, M.-P. Castanie-Cornet, and J. W. Foster, “Acid resistance systems required for survival of Escherichia coli O157:H7 in the bovine gastrointestinal tract and in apple cider are different,” Applied and Environmental Microbiology, vol. 70, no. 8, pp. 4792–4799, 2004.
- J. L. Slonczewski and J. W. Foster, “pH-regulated genes and survival at acidic pH,” in Escherichia coli and Salmonella: Cellular and Molecular Biology, F. C. Neidhardt, R. Curtiss III, J. L. Ingraham et al., Eds., vol. 1, pp. 1539–1549, ASM Press, Washington, DC, USA, 2nd edition, 1996.
- D. E. Conner and J. S. Kotrola, “Growth and survival of Escherichia coli O157:H7 under acidic conditions,” Applied and Environmental Microbiology, vol. 61, no. 1, pp. 382–385, 1995.
- G. J. Leyer, L.-L. Wang, and E. A. Johnson, “Acid adaptation of Escherichia coli O157:H7 increases survival in acidic foods,” Applied and Environmental Microbiology, vol. 61, no. 10, pp. 3752–3755, 1995.
- L. G. Miller and C. W. Kaspar, “Escherichia coli O157:H7 acid tolerance and survival in apple cider,” Journal of Food Protection, vol. 57, no. 6, pp. 460–464, 1994.
- R. D. Reinders, S. Biesterveld, and P. G. H. Bijker, “Survival of Escherichia coli O157:H7 ATCC 43895 in a model apple juice medium with different concentrations of proline and caffeic acid,” Applied and Environmental Microbiology, vol. 67, no. 6, pp. 2863–2866, 2001.
- M. M. Benjamin and A. R. Datta, “Acid tolerance of enterohemorrhagic Escherichia coli,” Applied and Environmental Microbiology, vol. 61, no. 4, pp. 1669–1672, 1995.
- R. C. McKellar and K. P. Knight, “Growth and survival of various strains of enterohemorrhagic Escherichia coli in hydrochloric and acetic acid,” Journal of Food Protection, vol. 62, no. 12, pp. 1466–1469, 1999.
- K. W. Arnold and C. W. Kaspar, “Starvation- and stationary-phase-induced acid tolerance in Escherichia coli O157:H7,” Applied and Environmental Microbiology, vol. 61, no. 5, pp. 2037–2039, 1995.
- F. Diez-Gonzalez, T. R. Callaway, M. G. Kizoulis, and J. B. Russell, “Grain feeding and the dissemination of acid-resistant Escherichia coli from cattle,” Science, vol. 281, no. 5383, pp. 1666–1668, 1998.
- J. Gorden and P. L. C. Small, “Acid resistance in enteric bacteria,” Infection and Immunity, vol. 61, no. 1, pp. 364–367, 1993.
- B. O'Driscoll, C. G. M. Gahan, and C. Hill, “Adaptive acid tolerance response in Listeria monocytogenes: isolation of an acid-tolerant mutant which demonstrates increased virulence,” Applied and Environmental Microbiology, vol. 62, no. 5, pp. 1693–1698, 1996.
- M. P. Doyle, “Escherichia coli O157:H7 and its significance in foods,” International Journal of Food Microbiology, vol. 12, no. 4, pp. 289–301, 1991.
- C. J. Reitsma and D. R. Henning, “Survival of enterohemorrhagic Escherichia coli O157:H7 during the manufacture and curing of cheddar cheese,” Journal of Food Protection, vol. 59, no. 5, pp. 460–464, 1996.
- S. F. Altekruse, B. B. Timbo, J. C. Mowbray, N. H. Bean, and M. E. Potter, “Cheese-associated outbreaks of human illness in the United States, 1973 to 1992: sanitary manufacturing practices protect consumers,” Journal of Food Protection, vol. 61, no. 10, pp. 1405–1407, 1998.
- L. Honish, G. Predy, N. Hislop et al., “An outbreak of E. coli O15:H7 hemorrhagic colitis associated with unpasteurized gouda cheese,” Canadian Journal of Public Health, vol. 96, no. 3, pp. 182–184, 2005.
- M. M. Arocha, M. McVey, S. D. Loder, J. H. Rupnow, and L. Bullerman, “Behavior of hemorrhagic Escherichia coli O157:H7 during the manufacture of cottage cheese,” Journal of Food Protection, vol. 55, pp. 379–381, 1992.
- H. Ramsaran, J. Chen, B. Brunke, A. Hill, and M. W. Griffiths, “Survivial of bioluminescent Listeria monocytogenes and Escherichia coli O157:H7 in soft cheeses,” Journal of Dairy Science, vol. 81, no. 7, pp. 1810–1817, 1998.
- M. M. Maher, K. N. Jordan, M. E. Upton, and A. Coffey, “Growth and survival of E. coli O157:H7 during the manufacture and ripening of a smear-ripened cheese produced from raw milk,” Journal of Applied Microbiology, vol. 90, no. 2, pp. 201–207, 2001.
- K. Jordan, L. Oxford, and C. P. O'Byrne, “Survival of low pH stress by Escherichia coli O157:H7: correlation between alterations in the cell envelope and increase acid tolerance,” Applied and Environmental Microbiology, vol. 65, no. 7, pp. 3048–3055, 1999.
- S. Massa, E. Goffredo, C. Altieri, and K. Natola, “Fate of Escherichia coli O157: H7 in unpasteurized milk stored at C,” Letters in Applied Microbiology, vol. 28, no. 1, pp. 89–92, 1999.
- G. Wang, T. Zhao, and M. P. Doyle, “Survival and growth of Escherichia coli O157:H7 in unpasteurized and pasteurized milk,” Journal of Food Protection, vol. 60, no. 6, pp. 610–613, 1997.
- N. Pradel, V. Livrelli, C. De Champs et al., “Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France,” Journal of Clinical Microbiology, vol. 38, no. 3, pp. 1023–1031, 2000.
- C. Vernozy-Rozand, M. P. Montet, M. Berardin, C. Bavai, and L. Beutin, “Isolation and characterization of Shiga toxin-producing Escherichia coli strains from raw milk cheeses in France,” Letters in Applied Microbiology, vol. 41, no. 3, pp. 235–241, 2005.
- I. Caro and M. R. García-Armesto, “Occurrence of Shiga toxin-producing Escherichia coli in a Spanish raw ewe's milk cheese,” International Journal of Food Microbiology, vol. 116, no. 3, pp. 410–413, 2007.
- A. Mora, S. L. León, M. Blanco et al., “Phage types, virulence genes and PFGE profiles of Shiga toxin-producing Escherichia coli O157:H7 isolated from raw beef, soft cheese and vegetables in Lima (Peru),” International Journal of Food Microbiology, vol. 114, no. 2, pp. 204–210, 2007.
- J. Rey, S. Sánchez, J. E. Blanco et al., “Prevalence, serotypes and virulence genes of Shiga toxin-producing Escherichia coli isolated from ovine and caprine milk and other dairy products in Spain,” International Journal of Food Microbiology, vol. 107, no. 2, pp. 212–217, 2006.
- R. Stephan, S. Schumacher, S. Corti, G. Krause, J. Danuser, and L. Beutin, “Prevalence and characteristics of Shiga toxin-producing Escherichia coli in Swiss raw milk cheeses collected at producer level,” Journal of Dairy Science, vol. 91, no. 7, pp. 2561–2565, 2008.
- K. E. Johnson, C. M. Thorpe, and C. L. Sears, “The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli,” Clinical Infectious Diseases, vol. 43, no. 12, pp. 1587–1595, 2006.
- A. E. Tozzi, A. Caprioli, F. Minelli et al., “Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988–2000,” Emerging Infectious Diseases, vol. 9, no. 1, pp. 106–108, 2003.
- D. Piérard, G. Cornu, W. Proesmans et al., “Hemolytic uremic syndrome in Belgium: incidence and association with verocytotoxin-producing Escherichia coli infection,” Clinical Microbiology and Infection, vol. 5, no. 1, pp. 16–22, 1999.
- A. Gerber, H. Karch, F. Allerberger, H. M. Verweyen, and L. B. Zimmerhackl, “Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997–2000, in Germany and Austria: a prospective study,” The Journal of Infectious Diseases, vol. 186, no. 4, pp. 493–500, 2002.
- E. Espié, F. Grimont, P. Mariani-Kurkdjian et al., “Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996–2006,” The Pediatric Infectious Disease Journal, vol. 27, no. 7, pp. 595–601, 2008.
- Centers for Disease Control and Prevention (CDC), “Outbreak of acute gastroenteritis attributable to Escherichia coli serotype O104:H21—Helena, Montana, 1994,” Morbidity and Mortality Weekly Report, vol. 44, no. 27, pp. 501–503, 1995.
- G. Deschênes, C. Casenave, F. Grimont et al., “Cluster of cases of haemolytic uraemic syndrome due to unpasteurised cheese,” Pediatric Nephrology, vol. 10, no. 2, pp. 203–205, 1996.
- P. Gallien, H. Richter, H. Klie et al., “Detection of STEC and epidemiological investigations in surrounding of a HUS patient,” Berliner und Munchener Tierarztliche Wochenschrift, vol. 110, no. 9, pp. 342–346, 1997.
- J. B. Wilson, R. C. Clarke, S. A. Renwick et al., “Vero cytotoxigenic Escherichia coli infection in dairy farm families,” Journal of Infectious Diseases, vol. 174, no. 5, pp. 1021–1027, 1996.
- M. Goodson and R. J. Rowbury, “Habituation to normally lethal acidity by prior growth of Escherichia coli at a sub-lethal acid pH value,” Letters in Applied Microbiology, vol. 8, no. 2, pp. 77–79, 1989.
- J. W. Foster, “The acid tolerance response of Salmonella typhimurium involves transient synthesis of key acid shock proteins,” Journal of Bacteriology, vol. 175, no. 7, pp. 1981–1987, 1993.
- J. W. Foster and H. K. Hall, “Adaptive acidification tolerance response of Salmonella typhimurium,” Journal of Bacteriology, vol. 172, no. 2, pp. 771–778, 1990.
- C. Vernozy-Rozand, C. Mazuy-Cruchaudet, C. Bavai et al., “Growth and survival of Escherichia coli O157:H7 during the manufacture and ripening of raw goat milk lactic cheeses,” International Journal of Food Microbiology, vol. 105, no. 1, pp. 83–88, 2005.
- J. Bouvet, M. P. Montet, R. Rossel et al., “Prevalence of verotoxin-producing Escherichia coli (VTEC) and E. coli O157:H7 in French pork,” Journal of Applied Microbiology, vol. 93, no. 1, pp. 7–14, 2002.
- M. Gourmelon, M. P. Montet, S. Lozach et al., “First isolation of Shiga toxin 1d producing Escherichia coli variant strains in shellfish from coastal areas in France,” Journal of Applied Microbiology, vol. 100, no. 1, pp. 85–97, 2006.
- C. Vernozy-Rozand, M. P. Montet, Y. Bertin et al., “Serotyping, subtyping, and characterization of the locus of enterocyte effacement island of Shiga toxin-producing Escherichia coli and E. coli O157:H7 strains isolated from the environment in France,” Applied and Environmental Microbiology, vol. 70, no. 4, pp. 2556–2559, 2004.
- T. M. Large, S. T. Walk, and T. S. Whittam, “Variation in acid resistance among Shiga toxin-producing clones of pathogenic Escherichia coli,” Applied and Environmental Microbiology, vol. 71, no. 5, pp. 2493–2500, 2005.
- Q. C. Truong, J.-C. Van Nguyen, D. Shlaes, L. Gutmann, and N. J. Moreau, “A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 1, pp. 85–90, 1997.
- G. Daufin, J.-P. Escudier, H. Carrère, S. Bérot, L. Fillaudeau, and M. Decloux, “Recent and emerging applications of membrane processes in the food and dairy industry,” Food and Bioproducts Processing, vol. 79, no. 2, pp. 89–102, 2001.
- B. Fremaux, S. Raynaud, L. Beutin, and C. V. Rozand, “Dissemination and persistence of Shiga toxin-producing Escherichia coli (STEC) strains on French dairy farms,” Veterinary Microbiology, vol. 117, no. 2–4, pp. 180–191, 2006.
- E. Heiss, “Rapid method for the determination of fat in cheese,” Deutsche Molkerei-Zeitung, vol. 82, pp. 67–70, 1966.
- H.-G. Yuk and D. L. Marshall, “Adaptation of Escherichia coli O157:H7 to pH alters membrane lipid composition, verotoxin secretion, and resistance to simulated gastric fluid acid,” Applied and Environmental Microbiology, vol. 70, no. 6, pp. 3500–3505, 2004.
- D. L. Archer, “Preservation microbiology and safety: evidence that stress enhances virulence and triggers adaptive mutations,” Trends in Food Science & Technology, vol. 7, no. 3, pp. 91–95, 1996.
- S. Buncic and S. M. Avery, “Effects of cold storage and heat-acid shocks on growth and verotoxin 2 production of Escherichia coli O157:H7,” Food Microbiology, vol. 15, no. 3, pp. 319–328, 1998.
- J. Samelis and J. N. Sofos, “Strategies to control stress-adapted pathogens,” in Microbial Stress Adaptation and Food Safety, pp. 303–351, CRC Press, Boca Raton, Fla, USA, 2003.
- R. L. Buchanan and S. G. Edelson, “Culturing enterohemorrhagic Escherichia coli in the presence and absence of glucose as a simple means of evaluating the acid tolerance of stationary-phase cells,” Applied and Environmental Microbiology, vol. 62, no. 11, pp. 4009–4013, 1996.
- J. Lin, M. P. Smith, K. C. Chapin, H. S. Baik, G. N. Bennett, and J. W. Foster, “Mechanisms of acid resistance in enterohemorrhagic Escherichia coli,” Applied and Environmental Microbiology, vol. 62, no. 9, pp. 3094–3100, 1996.
- J. E. Schlesser, R. Gerdes, S. Ravishankar, K. Madsen, J. Mowbray, and A. Y.-L. Teo, “Survival of a five-strain cocktail of Escherichia coli O157:H7 during the 60-day aging period of cheddar cheese made from unpasteurized milk,” Journal of Food Protection, vol. 69, no. 5, pp. 990–998, 2006.
- P. Marek, M. K. M. Nair, T. Hoagland, and K. Venkitanarayanan, “Survival and growth characteristics of Escherichia coli O157:H7 in pasteurized and unpasteurized Cheddar cheese whey,” International Journal of Food Microbiology, vol. 94, no. 1, pp. 1–7, 2004.
- C. Hsin-Yi and C.-C. Chou, “Acid adaptation and temperature effect on the survival of E. coli O157:H7 in acidic fruit juice and lactic fermented milk product,” International Journal of Food Microbiology, vol. 70, no. 1-2, pp. 189–195, 2001.
- T. M. Bergholz and T. S. Whittam, “Variation in acid resistance among enterohaemorrhagic Escherichia coli in a simulated gastric environment,” Journal of Applied Microbiology, vol. 102, no. 2, pp. 352–362, 2007.
Copyright © 2009 M. P. Montet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.